{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:24:37Z","timestamp":1786944277731,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate the incremental value of whole-tumor apparent diffusion coefficient (ADC) histogram parameters, when combined with clinical pathological variables for predicting extracapsular extension (EPE) in patients with PI-RADS 4\u20135 prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 102 patients with pathologically confirmed prostate cancer following surgery, comprising 51 patients with EPE and 51 without EPE as the training cohort, plus an independent temporal validation cohort of 34 patients. All patients underwent preoperative multiparametric magnetic resonance imaging (mpMRI). Tumor regions and 1\u20133 mm peritumoral regions of interest (ROIs) were manually segmented on ADC maps using 3D Slicer software, followed by the extraction of histogram parameters. Histogram features were selected using forward stepwise logistic regression based on the likelihood ratio test. Clinical, histogram, and combined predictive models were established using logistic regression analysis. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Internal validation was performed with 1000 bootstrap resamples to evaluate model stability and optimism. Calibration and decision curve analyses were further applied to assess model accuracy and clinical utility. To specifically quantify incremental value beyond the established clinical model, continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were defined as core secondary endpoints and calculated in the temporal validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariate Firth-corrected logistic regression analysis identified the International Society of Urological Pathology (ISUP) grade (OR\u00a0=\u00a02.701,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.033) and MRI-EPE score (OR\u00a0=\u00a05.441,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.020) as independent clinical predictors of EPE. Among the single-region histogram models, the peri_1mm model achieved the highest diagnostic performance (AUC\u00a0=\u00a00.839). Peri1_Minimum and peri3_Minimum were selected as the most informative histogram features for model construction. The combined model, incorporating ISUP grade, MRI-EPE score, peri1_Minimum, and peri3_Minimum, demonstrated the best overall performance with an AUC of 0.917, which was significantly higher than that of the histogram model alone (AUC\u00a0=\u00a00.858,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.026), while showing no significant difference compared with the clinical model (AUC\u00a0=\u00a00.903,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.336). Bootstrap internal validation yielded corrected AUC values of 0.904, 0.890, and 0.845 for the combined, clinical, and histogram models, respectively. The combined model also showed excellent calibration and provided greater net clinical benefit across a broader range of threshold probabilities on decision curve analysis. Notably, in the independent temporal validation cohort, although the combined model\u2019s AUC (0.861) remained numerically higher than that of the clinical model (0.818,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.208), the addition of peritumoral ADC histogram features resulted in a significant continuous NRI of 0.7286 (95% CI: 0.0971-1.3601,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.024) and a borderline significant IDI of 0.0919 (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.053), indicating that the addition of peritumoral ADC histogram features led to a net improvement in the direction of predicted risk changes, beyond what was provided by the clinical model alone. The combined model also showed good calibration, with a calibration slope of 0.710 (95% CI: 0.273\u20131.148) and a Brier score of 0.150.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integration of ISUP grade, MRI-EPE score, and peritumoral ADC histogram features (peri1_Minimum and peri3_Minimum) enables robust prediction of EPE in PI-RADS 4\u20135 prostate cancer. While the combined model\u2019s overall discriminatory performance was comparable to that of the clinical model based on AUC, the significant continuous NRI suggests incremental value in refining risk stratification. However, given the non-significant AUC difference and borderline IDI, these findings warrant validation in larger, multicenter cohorts before informing individualized surgical planning for high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1886143","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:34:33Z","timestamp":1786941273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of whole-tumor ADC histogram parameters combined with ISUP grade and MRI-EPE score for predicting extracapsular extension in PI-RADS 4\u20135 prostate cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Lei","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University","place":["Yangzhou, Jiangsu, China"]},{"name":"Department of Radiology, Rugao People\u2019s Hospital Affiliated to Kangda College of Nanjing Medical University","place":["Rugao, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University","place":["Yangzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University","place":["Yangzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University","place":["Yangzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuncheng","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Rugao People\u2019s Hospital Affiliated to Kangda College of Nanjing Medical University","place":["Rugao, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University","place":["Yangzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"Eau-eanm-estro-esur-ISUP-siog guidelines on prostate cancer-2024 update. Part i: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-024-01831-w","article-title":"What the urologist needs to know before radical prostatectomy: MRI effective support to pre-surgery planning","volume":"129","author":"Laschena","year":"2024","journal-title":"Radiol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.urolonc.2025.10.004","article-title":"Evaluation of PI-RADS version 2.1 vs. 2.0 for detecting clinically significant prostate cancer in biopsy-na\u00efve men","volume":"44","author":"Fink","year":"2025","journal-title":"Urol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41598-025-86607-6","article-title":"Development and validation of biopsy free nomograms for predicting clinically significant prostate cancer in men with PI-RADS 4 and 5 lesions","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jmri.26882","article-title":"Interobserver agreement of PI\u2010RADS v. 2 lexicon among radiologists with different levels of experience","volume":"51","author":"Mussi","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06092-0","article-title":"Low PI-RADS assessment category excludes extraprostatic extension (\u2265pT3a) of prostate cancer: A histology-validated study including 301 operated patients","volume":"29","author":"Alessi","year":"2019","journal-title":"Eur Radiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.241036","article-title":"A step closer to ADC as a biomarker in clinical practice","volume":"313","author":"Haider","year":"2024","journal-title":"Radiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00261-024-04227-6","article-title":"Histogram analysis of MR quantitative parameters: Are they correlated with prognostic factors in prostate cancer","volume":"49","author":"Chen","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-025-01879-2","article-title":"Biparametric mri in prostate cancer: Utility of whole-prostate and whole-lesion histogram and texture analysis for clinically significant prostate cancer","volume":"44","author":"Chen","year":"2025","journal-title":"Jpn J Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5114\/pjr\/205459","article-title":"The use of ADC histogram analysis in the diagnosis and determination of aggressiveness of peripheral zone prostate cancer","volume":"90","author":"\u015eara","year":"2025","journal-title":"Pol J Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jmri.26981","article-title":"Diagnosis of benign and Malignant breast lesions on DCE-MRI by using radiomics and deep learning with consideration of peritumor tissue","volume":"51","author":"Zhou","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-05069-6","article-title":"Preoperative risk assessment of endometrial cancer using histogram analysis of weighted and quantitative MRI images","volume":"51","author":"Palm\u00e9r","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-05096-3","article-title":"Study on the application value of histogram parameters from reduced field-of-view voi in rectal cancer","volume":"51","author":"Zhang","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-1614","article-title":"Histogram analysis based on intravoxel incoherent motion diffusion-weighted imaging for determining the perineural invasion status of rectal cancer","volume":"14","author":"He","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i38.4211","article-title":"Whole-volume histogram analysis of spectral-computed tomography iodine maps characterizes HER2 expression in gastric cancer","volume":"30","author":"Zhang","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1076400","article-title":"Incremental prognostic value of ADC histogram analysis in patients with high-risk prostate cancer receiving adjuvant hormonal therapy after radical prostatectomy","volume":"13","author":"He","year":"2023","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijrobp.2006.02.039","article-title":"Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension","volume":"65","author":"Chao","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1555315","article-title":"Prediction of bone metastasis of prostate cancer based on intratumoral and peritumoral radiomics of MRI T2WI combined with ADC images","volume":"15","author":"Lin","year":"2025","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/pas.0000000000001678","article-title":"The 2019 international society of urological pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"45","author":"Iczkowski","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110228","article-title":"Which one is better for predicting extraprostatic extension on multiparametric MRI: Esur score, likert scale, tumor contact length, or EPE grade","volume":"149","author":"Umut","year":"2022","journal-title":"Eur J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112149-20240911-00556","article-title":"Biparametric MRI-based peritumoral radiomics for preoperative prediction of extracapsular extension in prostate cancer","volume":"59","author":"Xu","year":"2025","journal-title":"Chin J Radiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4274\/dir.2023.232543","article-title":"Influence of image preprocessing on the segmentation-based reproducibility of radiomic features: In vivo experiments on discretization and resampling parameters","volume":"30","author":"Burak Ko\u00e7ak","year":"2024","journal-title":"Diagn INTERV Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28935","article-title":"The effect of image resampling on the performance of radiomics-based artificial intelligence in multicenter prostate MRI","volume":"59","author":"Bleker","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27678","article-title":"Multiparametric magnetic resonance imaging-based peritumoral radiomics for preoperative prediction of the presence of extracapsular extension with prostate cancer","volume":"54","author":"Bai","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018181278","article-title":"A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI","volume":"290","author":"Mehralivand","year":"2019","journal-title":"Radiology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.56434\/j.arch.esp.urol.20247702.28","article-title":"Predictive value of magnetic resonance imaging radiomics combined with serum PSA for the extracapsular extension of prostate cancer prediction","volume":"77","author":"Wu","year":"2024","journal-title":"Arch Esp Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/0284185119896520","article-title":"Diagnostic performance of whole-lesion apparent diffusion coefficient histogram analysis metrics for differentiating benign and Malignant breast lesions: A systematic review and diagnostic meta-analysis","volume":"61","author":"Xu","year":"2020","journal-title":"Acta Radiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2024.123557","article-title":"Breast cancer classification through multivariate radiomic time series analysis in DCE-MRI sequences","volume":"249","author":"Prinzi","year":"2024","journal-title":"Expert Syst Appl"},{"key":"B30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/diagnostics12020525","article-title":"Relationship between apparent diffusion coefficient distribution and cancer grade in prostate cancer and benign prostatic hyperplasia","volume":"12","author":"Saito","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25729","article-title":"Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer","volume":"47","author":"Krishna","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/15353508251393056","article-title":"Advancements in imaging technologies and AI integration for neurodegenerative disease management: A narrative review","volume":"24","author":"Xu","year":"2025","journal-title":"Mol Imaging"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/15353508241245265","article-title":"Combining nuclear medicine with other modalities: Future prospect for multimodality imaging","volume":"23","author":"Archibald","year":"2024","journal-title":"Mol Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.radonc.2018.01.014","article-title":"Estro acrop consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer","volume":"127","author":"Salembier","year":"2018","journal-title":"Radiother Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.20471\/acc.2022.61.s3.9","article-title":"MRI-guided radiotherapy for prostate cancer: a new paradigm","volume":"61","author":"Murgi\u0107","year":"2022","journal-title":"Acta Clin Croat"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1886143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:34:40Z","timestamp":1786941280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1886143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":35,"alternative-id":["10.3389\/fonc.2026.1886143"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1886143","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1886143"}}